Anuradha Singh, MD, FAAN (Neurology), FAES
Cards
Additional Titles
Clinical Chief of Epilepsy, Neurology
Director, Yale Epilepsy Center, Neurology
About
Titles
Medical School Recruit - Professor
Clinical Chief of Epilepsy, Neurology; Director, Yale Epilepsy Center, Neurology
Biography
Dr. Anuradha Singh is a Professor of Neurology and Neurosurgery and Clinical Chief and Director of Yale Comprehensive Epilepsy Center. She comes to the Yale Comprehensive Epilepsy Center after serving as Director of Epilepsy Monitoring Unit at Mount Sinai Hospital and Vice Chair of Outreach of the Neurology Division at Mt. Sinai. Prior to this, Dr. Singh served as a distinguished faculty member in the Department of Neurology at NYU Langone Health. She founded Bellevue Epilepsy Center and directed the Continuous EEG Monitoring Program at Bellevue Hospital for almost ten years. She was appointed as the Chief of Neurology and Clinical Professor of Neurology at NYC H+H/Bellevue in 2014, and served as a Chair of Credentialing and Bylaws Committee at Bellevue and Emeritus Professor, Bellevue Hospital. As one of the core teaching faculty members, she served as a program director of both Adult Neurology and Combined Neurology and Psychiatry programs at NYU Langone Health.
Appointments
Departments & Organizations
Education & Training
- Clinical Neurophysiology/EEG Fellowship
- NYU School of Medicine (2002)
- Neurology Residency
- NYU School of Medicine (2000)
- Internship
- Wyckoff's Heights Medical Center (1997)
- MD
- Lady Hardinge Medical College, Medicine (1987)
- MD
- Lady Hardinge Medical College (1987)
- BSC
- Hansraj College, Delhi University (1982)
Research
Overview
Medical Subject Headings (MeSH)
ORCID
0000-0001-9714-9095
Research at a Glance
Yale Co-Authors
Publications Timeline
Research Interests
Ji Yeoun Yoo, MD
Hitten Zaveri, PhD
Imran Quraishi, MD, PhD
Jennifer Ahjin Kim, MD/PhD
Lauren Hachmann Sansing, MD, MS, FAHA, FANA
Lawrence Hirsch, MD
Publications
2024
Neuropsychiatric complications of coronavirus disease 2019: Mount Sinai Health System cohort study
Gururangan K, Peschansky V, Van Hyfte G, Agarwal P, Blank L, Mathew B, Goldstein J, Kwon C, McCarthy L, Cohen A, Chan A, Deng P, Dhamoon M, Gutzwiller E, Hao Q, He C, Klenofsky B, Lemus H, Marcuse L, Navis A, Heredia Nunez W, Luckey M, Schorr E, Singh A, Tantillo G, Ufongene C, Young J, Balchandani P, Festa J, Naasan G, Charney A, Nadkarni G, Jetté N. Neuropsychiatric complications of coronavirus disease 2019: Mount Sinai Health System cohort study. Journal Of Neurology 2024, 271: 3991-4007. PMID: 38656620, DOI: 10.1007/s00415-024-12370-9.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsIn-hospital mortalityAssociated with lower oddsHigher odds of mortalityResultsOur study cohortElectronic medical record databaseChart reviewNeuropsychiatric complicationsNew York City health systemOdds of mortalityAssociated with in-hospital mortalityMultivariate logistic regressionMedical record databaseHealth systemLower oddsHigher oddsIndividual chart reviewSerum inflammatory marker levelsCohort studyPre-existing comorbiditiesRecord databaseCOVID-19Logistic regressionTreated with anticoagulationInflammatory marker levelsComplication of coronavirus diseaseElevated phase amplitude coupling as a depression biomarker in epilepsy
Young J, Chan A, Jette N, Bender H, Saad A, Saez I, Panov F, Ghatan S, Yoo J, Singh A, Fields M, Marcuse L, Mayberg H. Elevated phase amplitude coupling as a depression biomarker in epilepsy. Epilepsy & Behavior 2024, 152: 109659. PMID: 38301454, PMCID: PMC10923038, DOI: 10.1016/j.yebeh.2024.109659.Peer-Reviewed Original ResearchCitationsAltmetricConceptsBeck Depression Inventory-IIPhase-amplitude couplingComorbid depressionAssessment of depressive symptomsBeck Depression Inventory-II scoresAssociated with comorbid depressionAnterior cingulate cortexEpilepsy patientsAmplitude couplingPre-operative assessmentElevated phase-amplitude couplingSpectral powerOrbitofrontal cortexCingulate cortexPrimary depressionCase-control comparisonDepressive symptomsBrain regionsBrain activityDepression biomarkersAdult epilepsy patientsDepressionBrain recordingsPatient studiesTreatment targetHealth care access, psychosocial outcomes and mental health in adults living with epilepsy during the COVID-19 pandemic
Mc Carthy L, Mathew B, Blank L, Van Hyfte G, Gotlieb E, Goldstein J, Agarwal P, Kwon C, Singh A, Fields M, Marcuse L, Yoo J, Sivarak E, Gururangan K, Navis A, Jetté N. Health care access, psychosocial outcomes and mental health in adults living with epilepsy during the COVID-19 pandemic. Epilepsy & Behavior 2024, 151: 109617. PMID: 38219607, DOI: 10.1016/j.yebeh.2023.109617.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsPatient Health Questionnaire-9Generalized Anxiety Disorder-7Psychosocial outcomesMental healthHealthcare accessCancelled visitsCross-sectional study of adultsHealth care accessCOVID-19 pandemicMental health comorbiditiesPoor mental healthSocial support issuesPoor psychosocial outcomesSymptoms of anxietyCross-sectional studyStudy of adultsCare accessPsychosocial supportHealth comorbiditiesModerate/severe depressionHealth systemTelehealth visitsNeurological carePLWEStandardized questionnaire
2023
Older adults with epilepsy and COVID-19: Outcomes in a multi-hospital health system
Ufongene C, Van Hyfte G, Agarwal P, Goldstein J, Mathew B, Navis A, McCarthy L, Kwon C, Gururangan K, Balchandani P, Marcuse L, Naasan G, Singh A, Young J, Charney A, Nadkarni G, Jette N, Blank L, Group S. Older adults with epilepsy and COVID-19: Outcomes in a multi-hospital health system. Seizure 2023, 114: 33-39. PMID: 38039805, PMCID: PMC10841585, DOI: 10.1016/j.seizure.2023.11.018.Peer-Reviewed Original ResearchAltmetricMeSH Keywords and ConceptsConceptsInternational Classification of DiseasesLength of stayOlder adultsDischarge dispositionHigher in-hospital mortalityHealth systemIn-hospital deathIn-hospital mortalityMulti-hospital health systemOdds of in-hospital deathAssociated with increased oddsAssociated with increased odds of in-hospital deathNew York health systemMultivariate logistic regression modelClassification of DiseasesConsecutive older patientsAssociated with higher in-hospital mortalityLogistic regression modelsCompare in-hospital outcomesFactors associated with mortalityNon-routine discharge dispositionAssociated with higher ratesOlder peopleInternational ClassificationAdmitted with COVID-19Responsive Neurostimulation for People With Drug-Resistant Epilepsy and Autism Spectrum Disorder
Fields M, Marsh C, Eka O, Johnson E, Marcuse L, Kwon C, Young J, LaVega-Talbott M, Kurukumbi M, Von Allmen G, Zempel J, Friedman D, Jette N, Singh A, Yoo J, Blank L, Panov F, Ghatan S. Responsive Neurostimulation for People With Drug-Resistant Epilepsy and Autism Spectrum Disorder. Journal Of Clinical Neurophysiology 2023, 41: 64-71. PMID: 35512185, PMCID: PMC10756699, DOI: 10.1097/wnp.0000000000000939.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsDrug-resistant epilepsySuper respondersSeizure reductionPromising surgical optionResponsive neurostimulator systemRNS SystemAutism spectrum disorderSurgical candidatesSurgical evaluationSurgical optionsMulticenter studySpectrum disorderGeneral populationResponsive neurostimulationPatientsResponse rateSmall cohortEpilepsyNeurostimulator systemHigh rateRespondersDescriptive statisticsSystem placementBehavioral outcomesDisordersA multicenter retrospective study of patients treated in the thalamus with responsive neurostimulation
Fields M, Eka O, Schreckinger C, Dugan P, Asaad W, Blum A, Bullinger K, Willie J, Burdette D, Anderson C, Quraishi I, Gerrard J, Singh A, Lee K, Yoo J, Ghatan S, Panov F, Marcuse L. A multicenter retrospective study of patients treated in the thalamus with responsive neurostimulation. Frontiers In Neurology 2023, 14: 1202631. PMID: 37745648, PMCID: PMC10516547, DOI: 10.3389/fneur.2023.1202631.Peer-Reviewed Original ResearchCitationsAltmetricConceptsAnterior thalamic nucleiSerious adverse eventsGlobal Clinical Impression ScaleVagal nerve stimulationDrug-resistant epilepsyDeep brain stimulationAdverse eventsMost patientsResponsive neurostimulationSeizure reductionResective surgeryResistant epilepsyImpression ScaleSide effectsMedian baseline seizure frequencyDrug-resistant epilepsy patientsRare serious adverse eventsAnti-seizure medicationsDifferent epilepsy centersMeaningful seizure reductionMedian seizure reductionMedication regimen changesBaseline seizure frequencyMulticenter retrospective studyRetrospective multicenter studyIn‐hospital outcomes in patients with and without epilepsy diagnosed with COVID‐19—A cohort study
Ufongene C, Van Hyfte G, Agarwal P, Blank L, Goldstein J, Mathew B, Lin J, Navis A, McCarthy L, Gururangan K, Peschansky V, Kwon C, Cohen A, Chan A, Dhamoon M, Deng P, Gutzwiller E, Hao Q, He C, Nunez W, Klenofsky B, Lemus H, Marcuse L, Roberts M, Schorr E, Singh A, Tantillo G, Young J, Balchandani P, Festa J, Naasan G, Charney A, Nadkarni G, Jetté N. In‐hospital outcomes in patients with and without epilepsy diagnosed with COVID‐19—A cohort study. Epilepsia 2023, 64: 2725-2737. PMID: 37452760, DOI: 10.1111/epi.17715.Peer-Reviewed Original ResearchMeSH Keywords and ConceptsConceptsLength of stayNon-routine dischargeCharlson Comorbidity IndexIn-hospital outcomesHigher Charlson comorbidity indexFactors associated with higher oddsIntensive care unitInternational Classification of DiseasesOlder ageAssociated with COVID-19 mortalityRegression modelsClassification of DiseasesDecreased LOSLonger length of stayLogistic regression modelsAssociated with mortalityHealth systemOrdinary least squares regression modelsCOVID-19 mortalityOlder adultsRetrospective study of patientsInternational ClassificationHigher oddsMulticenter health systemEvaluate in-hospital outcomesNeuroimaging findings and neurological manifestations in hospitalized COVID-19 patients: Impact of cancer and ventilatory support status
McCarthy L, Khegai O, Goldstein J, Belani P, Pawha P, Kihira S, Mathew B, Gururangan K, Hao Q, Singh A, Navis A, Delman B, Jette N, Balchandani P. Neuroimaging findings and neurological manifestations in hospitalized COVID-19 patients: Impact of cancer and ventilatory support status. PLOS ONE 2023, 18: e0283614. PMID: 36961861, PMCID: PMC10038284, DOI: 10.1371/journal.pone.0283614.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsHospitalized COVID-19 patientsMagnetic resonance imagingVentilatory supportNeurological manifestationsCOVID-19 patientsNeuroimaging findingsSupport statusImpact of cancerPolymerase chain reaction-confirmed COVID-19Mount Sinai Health SystemNon-cancer patientsAssociated with neurological manifestationsRetrospective observational studySinai Health SystemClinical neurological manifestationsHealth systemCentral nervous systemCOVID-19 cohortMorbidity associated with COVID-19Cancer statusAcute/subacute infarctionProthrombotic stateCOVID-19Systemic illnessFocal weakness
2022
Neuroimaging Findings & Neurological Symptoms in COVID-19 Patients with & without Cancer: A Retrospective Multi-Center Observational Study
McCarthy L, Khegai O, Goldstein J, Belani P, Pawha P, Kihira S, Mathew B, Gururangan K, Hao Q, Singh A, Navis A, Delman B, Jette N, Balchandani P. Neuroimaging Findings & Neurological Symptoms in COVID-19 Patients with & without Cancer: A Retrospective Multi-Center Observational Study. Proceedings Of The International Society For Magnetic Resonance In Medicine ... Scientific Meeting And Exhibition. 2022 DOI: 10.58530/2022/0734.Peer-Reviewed Original ResearchConceptsAssociated with neuroimaging abnormalitiesNeuroimaging abnormalitiesCOVID-19 patientsNeurological symptomsRetrospective multi-center observational studyNeurological manifestationsHospitalized COVID-19 patientsNeuroimaging findingsSignal hyperintensitiesMulti-center observational studyAcute/subacute infarctionNeuroimagingRetrospective analysisUltrahigh-Field 7T MRI of the Brain of COVID-19 Patients with Neurological Symptoms: An Initial Study
Rashid S, Khegai O, Jette N, Belani P, Pawha P, Saju S, Navis A, Mathew B, Goldstein J, Gururangan K, Hao Q, Singh A, Becker J, Delman B, Balchandani P. Ultrahigh-Field 7T MRI of the Brain of COVID-19 Patients with Neurological Symptoms: An Initial Study. Proceedings Of The International Society For Magnetic Resonance In Medicine ... Scientific Meeting And Exhibition. 2022 DOI: 10.58530/2022/2206.Peer-Reviewed Original Research
Academic Achievements & Community Involvement
activity American of Indian Neurologists in America
Professional OrganizationsProgram CommitteeDetails11/24/2022 - Presentactivity American Academy of Neurology
Professional OrganizationsMemberDetails07/01/1998 - Presentactivity American Epilepsy Society
Professional OrganizationsMemberDetails07/01/2000 - Presentactivity American Clinical Neurophysiology Society
Professional OrganizationsMemberDetails2002 - Presentactivity New York State Neurological Society
Professional OrganizationsBoard of DirectorsDetails2018 - Present
Clinical Care
Overview
Clinical Specialties
Board Certifications
Epilepsy
- Certification Organization
- AB of Psychiatry & Neurology
- Original Certification Date
- 2013
Clinical Neurophysiology
- Certification Organization
- AB of Psychiatry & Neurology
- Original Certification Date
- 2003
Neurology
- Certification Organization
- AB of Psychiatry & Neurology
- Original Certification Date
- 2001
Are You a Patient?
View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.
View Doctor ProfileGet In Touch
Contacts
Administrative Support
Locations
Lippard Laboratory of Clinical Investigation (LLCI)
Academic Office
15 York Street
New Haven, CT 06510
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.